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CLONAL ANALYSIS OF A HUMAN ANTIBODY RESPONSE
Quantitation of Precursors of Antibody-producing Cells
and Generation and Characterization of Monoclonal
IgM, IgG, and IgA to Rabies Virus
By YUJI UEKI, INNA S. GOLDFARB, NAGARADONA HARINDRANATH,
MILIND GORE,' HILARY KOPROWSKI,' ABNER L. NOTKINS,
AND PAOLO CASALI
From The Laboratory of Oral Medicine, National Institute of Dental Research,
National Institutes of Health, Bethesda, Maryland 20892; and
'The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104
The maturation of the specific antibody response to foreign antigens (Ags)' has
been thoroughly investigated in experimental animals (1-8) . A first in vivo exposure
to Ag induces a "primary" antibody response constituted mainly of IgM with rela-
tively low affinity for the inducing Ag. A second and any further exposure to the
same Ag evoke "secondaries" or "memory" responses that involve mainly IgG with
a higher affinity for the Ag. Although study ofthe human antibody response to some
Ags, e.g ., tetanus toxoid (TT) and keyhole limpet hemocyanin, has been attempted
(9-13), the enormous difficulty in generating human mAbs (14, 15) has hindered
the definition of the clonal basis of such responses .
The recent progress made in the generation of human mAb-producing cell lines
(14-21) and in the characterization of novel B cell subsets (22, 23) allowed us to inves-
tigate the human antibody response to self and exogenous Ags at the clonal level
(16-19) . In the present studies, we quantitated the circulating B cells committed to
the production of antibodies to rabies virus and determined their phenotype in healthy
humans before and after multiple administrations of inactivated rabies virus vac-
cine . Moreover, using EBV transformation and somatic cell hybridization techniques,
we constructed 10 cell hybrids secreting IgM, IgG, and IgA mAbs to the virus. We
found that in the preimmune B cell repertoire, circulating lymphocytes committed
to the production ofvirus-binding IgM, but not IgG or IgA antibodies, are present
in high number. These cells are surface CD5+ and the antibodies they produce are
polyreactive and low affinity. After vaccination with inactivated rabies virus, B lym-
phocytes producing monoreactive high affinity IgG and IgA antibodies to the virus
consistently appear in the circulating . Most ofthese cells are surface CD5- and ac-
count for >10% of the total IgG- and IgA-producing cell precursors, respectively.
Address correspondence to Paolo Casali, Bldg. 30, Rm. 121, National Institutes of Health, Bethesda,
MD 20892 . Yuji Ueki's present address is the First Department of Internal Medicine, Faculty of Medi-
cine, Kyuhsu University, Fukuoka, 812 Japan .
Abbreviations used in this paper: Ag, antigen ; HDCV, human diploid cell vaccine ; Ins, insulin; RNP,
ribonucleoprotein complex ; TT, tetanus toxoid .
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HUMAN MONOCLONAL ANTIBODIES TO RABIES VIRUS
One of the IgG mAbs we generated using these cells efficiently neutralized the virus
in vitro and in vivo (Dietzschold, B., P. Casali, Y. Ueki, M. Gore, C. E . Rupprecht,
A. L . Notkins, and H. Koprowski, manuscript submitted for publication) . Finally,
the characterization of the V gene segments of these human mAbs to rabies virus
suggested that no relationship may exist in the clonal origin of the (early) low affinity
IgM and the (late) high affinity IgG or IgA produced in response to the virus .
Materials and Methods
Vaccination with Inactivated Rabies Virus . The recently introduced human diploid cell vac-
cine (HDCV) against rabies virus is consistently more immunogenic and safer than the prepa-
rations previously used (24) . Preventive vaccination with HDCV is required for all labora-
tory personnel involved in handling rabies virus . Before handling the virus, four healthy
laboratory workers (three males and one female, 30-52 yr old) were vaccinated with /3-pro-
piolactone-inactivated HDCV (PM-1503-3M strain) (Merieux Immunovax Rabies Vaccine ;
Merieux Institute, Inc ., Miami, FL) according to the recommended schedule. These sub-
jects received one intradermal dose of vaccine on days 0, 7, and 21 ; three of them received
a fourth ("booster") injection on day 142 . Venous blood (50 ml) was obtained on day -1 (be-
fore vaccination) and on days 7, 14, 28, 52, and 163 after the first injection . One subject
(B) provided 450 ml instead of 50 ml of blood on days -1 and 52 .
Preparation ofPBMC andB Lymphocytes. PBMC were separated from peripheral blood and
T lymphocytes were removed as previously decribed (25) . The remaining cells contained
N25% B lymphocytes, as defined by (BI) mAb directed to CD20 (Coulter Electronics; Inc.,
Hialeah, FL), <1% T cells, and variable proportions of monocytes, NK cells, and dendritic
cells (25) . This PBMC preparation is referred to here as B cells. CD5' and CD5- B cells
were purified from total B cells using phycoerythrin-conjugated BI mAb to CD20, FITC-
conjugated mAb to CD5', and a FAGS as described in detail (22, 23, 25) .
Titration of Total IgM, IgG, or IgA andAntibodies with Various Ag-bindingActivities. IgM, IgG,
or IgA concentrations were measured using appropriate ELISAs as described (16-18) . For
titration of IgM, IgG, and IgA to various Ags, plates (Beckman Instruments, Inc., Palo Alto,
CA) were coated with 10 tag/ml of purified human IgG Fc fragment (52,000 mol wt), ssDNA
(500,000 mol wt), 1 ug/ml of purified TT (110,000 mol wt), or 2.5 ug/ml of recombinant
human insulin (Ins) (6,000 mol wt ; a gift from Dr. W. R . Fields, Lilly Research Laboratories,
Indianapolis, IN) (18) . Antibody to rabies virus components was assayed using plates coated
with disrupted rabies virus (ERA strain, 5 jig/ml) that had been purified as described (26).
The virus glycoprotein (G ; 62,000 mol wt), ribonucleoprotein complex (RNP) (nucleoprotein,
N, 55,000 mol wt ; nonstructural protein, NS, 40,000 mol wt ; polymerase, L, 120,000 mol
wt), and membrane protein (M, 20,000 mol wt) were readily accessible to antibody on the
coated plate . Reference binding curves were constructed as described (16-18) . Specific horse-
radish peroxidase- or alkaline phosphatase-conjugated affinity-purified goat antibodies were
used to detect /A, y, H, and u, X L chains (Cappel Laboratories, Malvern, PA, and Sigma
Chemical Co., St . Louis, MO), as well as al and a2 H chains (The Binding Site Inc., San
Diego, CA) . Alkaline phosphatase-conjugated specific mouse mAbs were used to detect the
different IgG subclasses (ICN ImmunoBiologicals, Lisle, IL) . Substrate conversion was mea-
sured as absorbance at 492 or 415 nm using an automated ELISA reader (Titertek Multiskan
Plus ; Flow Laboratories, McLean, VA) .
EBV Infection and Culture of B Cells : Determination of Frequencies of Antibody-producing Cell
Precursors. Concentrated EBV` (5 x 106 transforming U/ml) was prepared as described (25) .
B cells (up to 5 x 10') were resuspended in a freshly thawed 1 .0-ml EBV aliquot and in-
cubated at 37°C for 2 h . After addition of fresh FCS-RPMI (RPMI 1640 medium [Biofluids,
Rockville, MD] containing 10% FCS [Gibco Laboratories, Grand Island, NY], L-glutamine
[2 mM], penicillin [50 IU/ml], and streptomycin [50 lAg/ml]), the cells were distributed in
limiting dilution microcultures (96-well round-bottomed plates ; Nunc Hazetlon, Denver, PA)
in presence of 105 syngeneic or allogeneic irradiated (1,800 rad) PBMC as feeders, as de-
scribed (16-18) . After a 4-wk culture, antibody concentration was determined in spent fluids .
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The criteria used for determination of positiveness have been reported (18) . The precursor
frequencies oftotal and rabies virus-binding IgM-, IgG-, or IgA-producing cells were calcu-
lated by analysis according to Poisson distribution (18) . The precursor frequency of virus-
binding IgM-, IgG-, and IgA-producing cells were expressed as percentages of total IgM-,
IgG-, and IgA-producing cell precursors, respectively (16-18) .
Human Monoclonal EBV-transformed Cell Lines and Construction of Somatic Cell Hybrids. Cell
lines producing antibodies binding rabies virus were established from EBVinfected lympho-
blasts by at least three sequential subculturing steps and then stabilized by fusion with F3B6
cells, an Ig nonsecretor, and HATsensitive and ouabain-resistant human-mouse hybrid (17-21) .
The resulting EBVtransformed B cell hybrids were cloned at 0.5 cell/well until all progeny
microcultures produced antibody to the virus . This required in general at least three cloning
steps . mAbs were prepared from culture fluids as described (18) .
Competitive Inhibition Studies and Kinetics ofDissociation ofHuman mAbs Binding to Solid-phase
Ag by SolubleAg. Aliquots ofPBS (0.05 ml) containing 0.057o Tween 20 and 0.1 17o BSA (PBS-
Tween) and 0.2-0.4 jig of mAb were mixed with aliquots of PBSTween (0.05 ml) containing
0.1% BSA and increasing amounts (0.1-200 hg) of soluble IgG Fc fragment (3.8 x 10 - a to
7 .1 x 10-5 M), ssDNA (4.0 x 10 - ' 2 to 8 .0 x 10" 6 M), Ins (3 .3 x 10" to 6.6 x 10-4 M),
TT (1.8 x 10 - " to 3 .6 x 10 -5 M), or rabies virus components, including the G (0.003-30
jig), the RNP (0.005-50 1~g), and the M (0.002-20 1~g) protein . After an 18-h incubation
at room temperature, the mixtures were transferred into ELISA plates precoated with IgG
Fc fragment, ssDNA, Ins, TT, or rabies virus . After 1-h incubation, the mAb bound to the
solid-phase Ag was measured . The Ag-binding activity of each mAb in the presence of free
ligand was expressed as percentage of its binding activity measured under identical condi-
tions but in absence of any free ligand (100% binding) . Dissociation constant (K,,, g/J,1 or
mol/liter) values were calculated as described (17, 18) .
Analysis of mAb V and V,r Gene Segments. DNA probes used in this study were amplified
after insertion into the appropriate plasmids or phage and transformation of Escherichia coli
strains DH5a (Bethesda Research Laboratories, Gaithersburg, MD) or LE392 (Pharmacia
Fine Chemicals, Piscataway, NJ) . The DNA inserts were prepared from plasmid DNA by
using the appropriate restriction enzymes, and these DNA fragments were labeled with deoxy-
cytidine 5'-a-[32p]triphosphate (dCTP) (sp act, 3,000 Ci/mmol ; Amersham Corp., Arlington
Heights, IL) by random priming oligolabeling (27) . The cDNA V  segment probes used
in these studies included : 51P1 (370 bp, V  I) (28), VCE-1 (310 bp, V  II) (29), 56P1 (460 bp,
V  III) (29), 58P2 (405 bp, V IV) (29), 83P2 (245 bp, V V), identical to V251 (30), 15P1
(350 bp, V VI) (28), and 20Pi (222 bp, VIIIb) (28) . The V  probes used included : Ml-3
(320 bp, VKI) (31), M607-A (290 bp, VKII) (31), Humkv 305/Pl (3 .1 kbp, VKIII) (32), and
EVJK2 (7.0 kbp, VKIV) (33) . Cellular RNA was extracted from human mAb-producing cell
lines by the guanidinium/cesium chloride method (34) . Total cellular RNA (10 1~g) was slot
blotted on Gene Screen Plus membranes (New England Nuclear, Boston, MA) in 50% (vol/vol)
deionized formamide and 6% (vol/vol) formaldehyde according to the manufacturer's pro-
tocol. Blots were prehybridized for 1 h and then hybridized with different V probes at 42°C
in 50% (vol/vol) deionized formamide, 5x SSC, 5% Denhardt's solution, 25 mM NaH2PO4 ,
pH 6.5, 1 % SDS, and 100 lag/ml ofdenatured salmon sperm DNA. After hybridization, blots
were washed at room temperature for 30 min in 2x SSC and 0.1% SDS, and then washed
at 65°C in 0 .1 x SSC and 0.1% SDS for 30 min . Autoradiography was performed using Kodak
XAR-5 film (Eastman Kodak Co., Rochester, NY) .
Results
Recruitment ofPrecursors ofCells Producing IgM, IgG, and IgA Antibodies to Rabies Virus
by Inactivated Vaccine. The efficacy of the vaccination procedure was evaluated by
measuring the kinetics of the plasma virus-neutralizing activity and the titer of cir-
culating IgM, IgG, and IgA antibodies binding rabies virus after the first, as well
as after each further rabies virus vaccine administration, in four healthy human volun-
teers . Before vaccination, these subjects did not display any significant virus-neu-
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tralizing activity, i.e ., <2 IU/ml (Fig . 1) . Their plasma virus-neutralizing titer, how-
ever, rose sharply as soon as 1 wk after the first vaccine injection and peaked, in
some cases to >200 IU/ml, 4 wk after the third injection. The sharp rise and subse-
quent steady level of the plasma virus-neutralizing activity paralleled the high con-
centrations of the plasma anti-rabies virus antibodies of the IgG, and, to a much
lesser extent, of theIgM or IgA class (Fig. 1) . The increase ofplasma virus-binding
IgM was paralleled in magnitude and with similar kinetics profile by an increase
in plasma IgM binding ssDNA, TT, and Ins (not shown) .
Because of the resting state of most lymphocytes in the normal B cell repertoire,
the definition of its diversity demands, as an absolute prerequisite, the use of apoly-
clonal B cell activator capable of inducing Ig production in each B lymphocyte clone.
We have previously shown that EBV is ideally suited for such a purpose in humans,
in that it induces transformation and Ig production with equal efficiency in B lym-
phocytes bearing different surface H chains, i.e ., j .e, y, or ct, as well as CD5+ and
CD5- B cells (16-21, 25). To quantitate the precursors of cells producing antibodies
to rabies virus, we obtained circulating B cells from the same four subjects and at
the same times used in the experiments described above. After EBV infection, these
cells were immediately plated in limiting dilution microculture assays . After a 4-wk
culture, the frequency ofcells producing virus-binding IgM, IgG, and IgA was de-
termined . Before any virus injection, the B cells committed to the production of
IgM-binding rabies virus constituted in some subjects up to 1.90 and 1 .74% oftotal
circulating precursors of cells producing IgM and Ig, respectively (Fig . 2, A and
A'). Their percentages increased two- to threefold 1 wk after the second vaccine in-
jection and returned to the prevaccination values as early as 1 wk after the third
vaccine injection (Fig. 2, A and A').
In contrast to IgM-producing cell precursors, circulating B cells committed to
the production ofIgG and IgA to rabies virus were not detectable (<0.005% of the
total IgG- and IgA-producing cell precursors, respectively, or <0.0005% of the total
Ig-producing cell precursors) in any subject before the primary vaccination (Fig.
2, B, B', C, and C'). However, these lymphocytes were detected in the circulation
as early as 1 wk after the first vaccine injection, when B cells committed to the produc-
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FIGURE 1. Kinetics of appearance of circulating
IgM, IgG, and IgA to rabies virus after immuniza-
tion with inactivated rabies virus vaccine. Rabies
virus vaccine was administered intradermally to four
healthy subjects on days 0, 7, 21, and 142 . Periph-
eral blood was obtained on days -1, 7, 14, 28, and
163 after the first vaccine injection . Plasma was sepa-
rated and tested using specific ELISA techniques for
rabies virus-binding IgM (O), IgG (A), and IgA (Q)
concentration, as well as for its in vitro virus-
neutralizing titer ("). Data are mean values t SD
(vertical bars) .
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tion of anti-rabies virus IgG and IgA accounted for up to 6.3 and 2.5% of total
IgG- and IgA-producing cells precursors, respectively (Fig . 2, B and C), or up to
0.34 and 0.15%, respectively, of total Ig-producing cell precursors (Fig. 2, B' and
C'). Their frequency peaked 1 wk after the third vaccine injection: anti-rabies virus
IgG- andIgA-producing cell precursors constituted up to 11 .0 and 12 .4% ofthe total
IgG- and IgA-producing cell precursors, respectively (Fig . 2, Band C). In each sub-
ject, thenumber ofthese cells was reduced by half or two-thirds 4 wk after the third
vaccine injection. After the fourth injection, the frequency of B cells committed to
the production of virus-specific IgG and, to a lesser extent, IgA antibodies returned
to the peak values observed after three vaccine injections (Fig . 2, B, B', and C, C').
In general, the rise in frequency ofthe circulating anti-rabies virus IgG-producing
cell precursors preceded the increase in plasma titer of the respective antibodies,
although this relationship was less marked in the case of anti-virus IgM and IgA
antibodies, the plasma concentration of whichnever reached the values of their IgG
counterpart (compare Fig. 2, B, B', C, and C' with Fig. 1) . This together with the
results of several limiting dilution experiments (not shown) involving the culture
ofnon-EBVinfected circulating B cells from vaccinated subjects suggested that most
B cells "committed" to the production of IgG to rabies virus were in fact actually
producing these antibodies .
Phenotype of the B Cells Committed to the Production ofAntibodies to Rabies Virus. We
have previously shown that in the normal human B cell repertoire a major propor-
tion (ti10-20°Jo of total B cells) of lymphocytes are committed to the production
of polyreactive, mainly IgM, antibodies, that bind a variety ofdifferent self and ex-
ogenous Ags (18, 19, 22, 23). These antibodies are produced by CD5+ B cells . These
lymphocytes account for the high frequency of cells committed to the production
of antibodies binding an exogenous Ag before any and after injection with the same
Ag. For example, in both subjects never exposed to TT and in those immunized
with TT, the vast majority of IgM antibodies binding TT are produced by CD5+
B cells (22, 23). These antibodies display a low affinity for TT and are polyreactive .
In contrast, the high affinity monoreactive IgG antibodies to TT found in T'T
vaccinated subjects are produced by CD5- B cells (18, 19, 22, 23). To determine
whether an analogous pattern of B cell commitment to low affinity IgM and high
affinity IgG antibodies exists in response to rabies virus, we purified CD5' and
CD5- B cells from one volunteer before and after vaccination, infected these cells
with EBV, and cultured them to assess the reactivity of the antibodies produced .
Consistent with the B cell subsets segregation pattern observed in the antibody re-
sponse to TT (22), the virus-binding IgM detected before immunization with rabies
virus and the vast majority of those detected 4 wk after the third vaccine injection
were produced by CD5+ B cells ; the vast majority of the IgG antibodies detected
only after vaccination were produced by CD5- B cells (Fig. 3) .
Generation and Characterization of Human mAbs to Rabies Virus. To characterize the
antibodies produced in response to rabies virus, we generated, by EBVtransformation
and somatic hybridization techniques, eight mAb-producing continuous cell lines
using circulating lymphocytes obtained from three subjects at different times during
immunization . Because of the overrepresentation of the B cells committed to the
production of IgM in the human B cell repertoire (18, 19, 25), when utilizing B
cells from immunized subjects, we deliberately biased the selection of rabies virus-
UEKI ET AL .
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FIGURE 3 . Production of rabies virus- bind-
ing antibodies by CD5` and CD5- B cells be-
fore and after vaccination with inactivated ra-
bies virus vaccine . CD5* and CD5- B PBL
were purified from a subject before vaccina-
tion and 52 d after the third vaccine injection .
These cells were infected with EBV and cul-
tured in microplates at 250/well in presence
of irradiated feeders . After a 4-wk culture,
fluids were tested for antibody activity. Each
dot represents the concentration ofantibody
(expressed as absorbance at 492 nm) in the
fluid from one microculture well . Approxi-
mately 50 microculture wells were assayed in
each column .
binding antibody-producing cells in favor of those clones producing IgGor IgA over
those producing IgM. Three ofthese mAb-producing EBVtransformed hybrid cells
made IgM, four made IgG, and one made IgA. The features of these eight mAbs
were compared with those of two other IgM mAbs produced by EBVtransformed
hybrid cells generated from two of the same subjects before primary rabies virus
vaccination (Table I) . All IgM mAbs (Ab 50, 51, 52, 55, and 59) bound to the RNP
complex, in most cases, to its N component. The IgA mAb (Ab 105) and one of
the IgG (Ab 56) mAbs also bound to the RNP complex (N component) ; one of the
IgG mAbs (Ab 53) bound to the M protein; and the remaining two IgG mAbs (Ab
53 and 57) bound to the G protein. One (Ab 57) of the two rabies virus G-binding
IgG mAbs efficiently neutralized the virus in vitro and in vivo (Dietzschold, B., P.
Casali, Y. Ueki, M. Gore, C. E. Rupprecht, A. L. Notkins, and H . Koprowski,
manuscript submitted for publication) .
To study in further detail the Ag-binding activity of these antibodies, each mAb
was tested at different concentrations for binding to solid-phase virus components,
as well as to different self Ags (Fc fragment of human IgG, ssDNA, and Ins) and
non-self Ags (TT) . The binding curves derived from the analysis of the two IgM
mAbs generated from cells obtained before immunization and one of the two IgM
mAbs generated after completion ofthe immunization schedule (Table I) are depicted
in Fig. 4, A, B, and C. These IgM mAbs were polyreactive and bound in a dose-
dependent fashion not only to rabies virus components, but also and with different
efficiency, to other Ags included in the assays . Assay of the binding activity of the
remaining two IgM mAbs, one generated after the first vaccine injection and one
generated after the fourth, gave similar results (not shown) . In contrast, the four
IgGand one IgA mAbs generated from two fully immunized subjects were monoreac-
tive, binding in a dose-dependent fashion only to rabies virus components, and to
none of the other Ags tested . Fig. 4, D, E, and F shows the binding curves derived
from the analysis of the IgA mAb and two of the four IgG mAbs; assay of the re-
maining two IgG mAbs gave similar results (not shown) .
The polyreactivity of the IgM as well as the monoreactivity of the IgG and IgA
mAbs were confirmed by the results of competitive inhibition experiments, in which
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the binding of each mAb to solid-phase rabies virus was measured in the presence
of homologous (rabies virus) or heterologous free Ags. Thebinding of mAb50, mAb52,
and mAb55 to solid-phase rabies virus was inhibited, in general inefficiently, by free
virus components as well as by different soluble heterologous Ags, including TT,
ssDNA, and Ins (Fig . 4, A', B', and C'). The converse was also true : the binding
of each IgM mAb to solid-phase Fc fragment, ssDNA, Ins, or TT was inhibited
not only by the soluble homologous Ag, but also by the soluble heterologous Ags,
as well as free rabies virus (not shown) . Competitive inhibition analysis of the two
remaining IgM mAbs provided similar results (not shown) . Unlike the binding of
polyreactive IgM mAbs, the binding of the monoreactive IgG and IgA mAbs to
solid-phase rabies virus components was inhibited very efficiently and in a dose-
dependent fashion by free rabies virus components, but not by any of the other soluble
Ags tested . These results are exemplified by the inhibition curves derived from the
analysis of mAb105, mAb57, and mAb53 (Fig . 4, D', E', and F') .
Competitive inhibition experiments involving pairs (solid and free phase) of ho-
mologous ligands allowed for the calculation of the Kd of the mAbs for the different
Ags studied. The polyreactive IgM mAbs displayed relatively high Kd values (low
affinity) for rabies virus (>10-6 g/ul) and for the other ligands tested (-10-4-10 -6
mol/liter) (Table I) . In sharp contrast, the monoreactive IgG and IgA mAbs dis-
played Kd values for rabies virus three to four orders of magnitude lower (-10-9-
10-10 g/A.1) (higher affinity) than those displayed by the polyreactive mAbs. The Kd
values of monoreactive mAbs for Ags other than rabies virus were too high (>5.0 x
10-3 mol/liter) to be calculated (very low affinity) .
V,, and Vr Gene Segments Usage by the mAbs to Rabies Virus. It has been reported
that polyreactive antibodies and certain rheumatoid factors may use selected V and
VL segments (35, 36). Probing of the slot-blotted RNA from the 10 different mAb-
producing cell lines using seven different ["P]cDNA segments, corresponding to
membersofthe six conventional V families (V I through VVI) and to a segment
(20P1) only distantly related to the VIII family, V111b (28, 37), revealed two dis-
crete patterns of V gene segment utilization by the polyreactive and the monoreac-
tive mAbs . RNA from all five polyreactive IgM mAb-producing cell lines hybrid-
ized with the 20P1 V cDNA probe (Table I) . In contrast, RNA from only one
(mAb 53, an IgGI) of the five monoreactive high affinity mAb-producing cell lines
hybridized with the 20P1 V cDNA (Table 1) . The hybridization of RNA from the
remaining four monoreactive high affinity mAb-producing cell lines showed that
two mAbs, an IgG2 and an IgAl, utilized members of the VIII and VVI fami-
lies, respectively (Table I) ; the other two mAbs, both IgG2, utilized members of the
VI and the VIV gene families. None of the mAbs utilized gene segment members
of the VII or VV gene families . Probing of the slot-blotted RNA from the seven
K+ mAb-producing cell lines using four different [s 2P]DNA segments (members of
the VK I, 11, 111, and IV families) revealed a preferential utilization of VKIII family
gene segments by the polyreactive IgM antibodies . Three of the four K+ IgM mAbs
used a gene segment member of the VKIII family. The remaining mAb utilized a
segment member of the VKII gene family. In contrast, only one ofthe three K+ IgA
and IgG mAbs utilized a segment member of the VKIII gene family ; the remaining
two utilized members of the VKI gene family (Table I) . None of the mAbs utilized
members of the VKIV gene family.
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Discussion
Thepresent studies showed that in humans not previously exposed to rabies virus,
a major proportion of circulating B lymphocytes (up to 2% of total Ig-producing
cell precursors) are committed to the production of rabies virus-binding IgM, but
not IgG or IgA (<0.0005% of total Ig-producing cell precursors). Exposure to ra-
bies virus brings about a dramatic change in the B cell repertoire . After three vac-
cine injections, B cells committed to the production of IgG and IgA to the virus
consistently appeared in high number in the circulation, accounting for up to al-
most 1% of total Ig-producing cell precursors . In contrast, circulating B cells com-
mitted to the production of IgM capable of binding rabies virus increased only by
a factor of two to three, accounting for up to N5% of total Ig-producing cell
precursors .
The anti-rabies virus IgG and IgA antibodies displayed a discrete pattern of Ag
reactivity when compared with their IgMcounterparts . In fact, the IgM mAbs pro-
duced by B cells obtained either before or, even, after immunization displayed a
low affinity for rabies virus (Kd, >10 -6 g/Ecl) and were polyreactive . In contrast, the
anti-rabies virus IgG and IgAmAbs produced by B cells obtained after immuniza-
tion were monoreactive and displayed a high affinity for the virus (Kd, -10 -9-
10-1 ° g/Al). Thus, the virus binding is but one of many Ag-binding activities ex-
pressed by the polyreactive IgM antibodies . These likely belong to the broader class
of antibodies defined as "natural antibodies" (17-19, 22, 38-44) . Their polyreactivity
and low affinity suggest that the primary B cell repertoire may be largely Ag inde-
pendent in its generation, although Ag-induced IgMwith higher affinity might have
also participated in the rabies virus-induced response . Such antibodies, however,
wouldhave been produced by cells present only at very low frequency in the circula-
tion, and perhaps missed by our sampling procedure, i.e ., mAb generation.
The present experiments also showed that regardless of the specific immune status
of a subject, the B cells committed to the production ofpolyreactive low affinity IgM
binding to rabies virus are surface CD5+ . In contrast, in immunized subjects, those
committed to the production of monoreactive high affinity IgG are mainly surface
CD5- . This is consistent with our earlier observations suggesting that the CD5-
B cell compartment provides, or at least contains, the lymphocytes responsible for
a secondary, high affinity "mature" antibody response, as well as high affinity memory
B cells (18, 22).
The low affinity polyreactive IgM mAbs selected for binding to rabies virus were
restricted both in Ag reactivity and in V gene family utilization . Indeed, all of the
IgM mAbs recognized the rabies virus RNP complex, mainly its N component,
and all utilized V segment members of the same gene family, as determined by
positive hypridization of their RNA with the 20P1 cDNA probe. The selective utili-
zation of VL gene members of the same family (V,,III) by three of four of the V,c+
IgM mAbs further underlines their genetic homogeneity. The 20P1 VH DNA seg-
ment was originally derived from a fetal liver library of expressed V segments (28)
and is utilized in unmutated configuration in a human IgM mAbwith anti-self(Sm)
reactivity (37) . This V segment shares sequence homology with some members
of the conventional VIII family, although its allocation in the VIII family may
be questionable and might well constitute a member of a yet to be defined V sub-
family, tentatively named VIIIb (37) .
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The shift from low to high specificity and affinity in the antibody response to ra-
bies virus coincided with the utilization of a variety of different V and V,, gene
segments by most ofthe participating cell clones. Only one(mAb53, a monoreactive
IgG2) of the five high affinity mAbs generated from the immunized subjects used
a member of the VIIIb gene family. However, unlike the polyreactive low affinity
IgM, mAb53 was specific for the viral M, not N component. Thus, unless an im-
probable gene replacement mechanism (45) was operative in the response to rabies
virus, most of the B cells recruited in the late high affinity antibody response were
likely the progeny of clones different from those committed to the production ofpoly-
reactive IgM antibodies . A similar shift from a V gene family restricted primary
response to a more diverse V gene segment utilization in the mature, secondary,
or tertiary response is exemplified by BALB/c mice responding to oxazolone (7).
This contrasts with the clonal dominance of a single V family in both the primary
andsecondaryimmune responses, as exemplified by the response to phosphorylcho-
line in similar BALB/c mice (3), or by the response to arsonate in A/J mice (6).
Acomparable pattern of clonal dominance throughout the maturation of the human
antibody response may be found when analyzing the specific antibodies generated
by immunization with an Ag of different nature, e.g., polysaccharides.
The utilization of a VIIIb gene segment by one of the monoreactive high affinity
"secondary" antibodies maybe compatible with the hypothesis that a minor compo-
nent ofan Ag-driven "mature" antibody response to rabies virus is due to the progeny
of cells originally producing polyreactive "autoantibodies" and using selected, e.g .,
VIIIb, gene segments . These cells would undergo an Ag-driven process of clonal
expansion and somatic point mutation with simultaneous loss of the surface CD5
molecule ; in vitro proliferation of normal CD5+ B cells can be associated with loss
of the CD5 expression (23, 46). In A/J mice, B cells producing antiarsonate anti-
bodies after active immunization are thought to be the progeny of virgin B lympho-
cytes originally making Ig with unmutated V gene segments and endowed with
multiple "anti-self" reactivity (47). Maturation ofthe antibody response to arsonate
parallels class switch from IgM to IgG, increasing number of point mutations in
the Ig V gene segments, and loss of "anti-self" reactivity. Sequencing of the gene
segments encoding the V regions ofthe polyreactive low affinity, as well as monoreactive
high affinity, antibodies to rabies virus will help to unequivocally identify these genes
and to elucidate the possible contribution of Ag-selected somatic point mutations
to the affinity of such antibodies .
The inability to easily culture Ag-induced antibody-producing cells and to use
them to construct continuous mAb-producing human cell lines has been the major
impediment in the study of the human B cell function and repertoire (14, 15). In
the present studies, by applying recently developed methods (16-21) to the analysis
oflymphocytes obtained from volunteers immunized with rabies virus, we have defined
the properties of the B cell clones recruited through the progression of the immune
response from polyreactive low affinity to monoreactive high affinity antibodies .
Moreover, we have demonstrated that human IgG mAbs ofpredetermined specificity
and high affinity and with, possibly, important biological activities (e.g ., virus neu-
tralization) can be systematically generated from the Ag-primedhumanB cell reper-
toire. This approach may be used to analyze the specific antibody response to other
foreign Ags or selfAgs in humans . It also may be used, as shown elsewhere (Dietz-
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schold, B., P Casali, Y. Ueki, M. Gore, C. E . Rupprecht, A. L . Notkins, and H.
Koprowski, manuscript submitted for publication), to generate human mAbs for
immediate application in vivo.
Summary
We quantitated and characterized the changes in the human B cell repertoire,
at the clonal level, before and after immunization with rabies virus . Moreover, we
generated 10 monoclonal cell lines producing IgM, IgG, and IgA antibodies to the
virus . We found that in healthy subjects, not previously exposed to the virus, nearly
2 % ofthe circulating B lymphocytes were committed to the production ofantibodies
that bound the virus . These B cells expressed the surface CD5 molecule . The anti-
bodies they produced were polyreactive IgM that displayed a relatively low affinity
for the virus components (Kd, 1.0-2.4 x 10-6 g/Al) . After immunization, different
anti-virus (IgG and IgA) antibody-producing cells consistently appeared in the cir-
culation and increased from <0.005% to >10% of the total B cells committed to
the production of IgG and IgA, respectively. Most of such B cells do not express
CD5 and produce monoreactive antibodies of high affinity for rabies virus (Kd, 6.5 x
x 10-9 to 1 .2 x 10-1° g/A1) . One of these IgG mAbs efficiently neutralized rabies
virus in vitro and in vivo, as detailed elsewhere (Dietzschold, B., P Casali, Y. Ueki,
M. Gore, C . E . Rupprecht, A. L . Notkins, and H. Koprowski, manuscript sub-
mitted for publication) . Hybridization experiments using probes specific for the
different human V gene segment families revealed that cell precursors producing
low affinity IgM binding to rabies virus utilized a restricted number of V  gene seg-
ments (i .e ., only members of the VHIIIb subfamily), whereas cell precursors
producing high affinity IgG and IgA to rabies virus utilized an assortment of different
V gene segments (i .e ., members of theV1, VIII, VIV, and V VI families and
VIIIb subfamily) .
In conclusion, our studies show that EBV transformation in conjunction with lim-
iting dilution technology and somatic cell hybridization techniques are useful methods
for quantitating, at the B cell clonal level, the human antibody response to foreign
Ags and for generating human mAbs of predetermined specificity and high affinity.
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